Stanford Diabetes Research Center

斯坦福糖尿病研究中心

基本信息

批准号：
9442588
负责人：
Seung K Kim
金额：
$ 156.85万
依托单位：
STANFORD UNIVERSITY
依托单位国家：
美国
项目类别：
财政年份：
2017
资助国家：
美国
起止时间：
2017-09-15 至 2022-06-30
项目状态：
已结题

来源：
https://reporter.nih.gov/project-details/9442588
关键词：
ATAC-seq Abbreviations American Apple Area Award Awareness Basic Science Beta Cell Biological Assay Biological Sciences Biomedical Research California Cardiovascular Diseases Cardiovascular system Caring Cellular biology Chemistry Child health care Chromatin Clinical Clinical Research Clinics and Hospitals Collaborations Communication Communities Development Diabetes Mellitus Diabetes prevention Diagnosis Discipline Education Engineering Environment Event Evolution Faculty Family Fostering Foundations Funding Future Genetic Genomics Goals Growth Health Health Personnel Heart Human Humanities Immunologic Monitoring Industrialization Institutes Insulin-Dependent Diabetes Mellitus Interdisciplinary Study International Kidney Kidney Diseases Knowledge Leadership Learning Letters Malignant neoplasm of pancreas Medicine Mentors Metabolism Mission Modernization Natural regeneration Non-Insulin-Dependent Diabetes Mellitus Obesity Occupations Pancreas Patients Pediatric Hospitals Phenotype Principal Investigator Recruitment Activity Research Research Institute Research Personnel Research Support Research Training Resources Risk-Taking San Francisco Schools Science Scientist Services Silicon Strategic Planning Stroke Supervision Surgically-Created Resection Cavity T-Lymphocyte Technology Training Training Programs Translating Translational Research Translations United States National Institutes of Health Universities Work base chimeric antigen receptor chronic pancreatitis clinical care improved innovation insulin sensitivity islet mHealth medical schools member multidisciplinary next generation outreach outreach program programs ranpirnase research clinical testing research study scientific organization

项目摘要

Center overview abstract The Stanford Diabetes Research Center (SDRC) embodies the culmination of a long-term strategic plan by the Stanford University School of Medicine to create a premier program founded on a base of superb, collaborative investigators studying basic, clinical and translational problems focused on improving diabetes care. Support of this P30 application will leverage diabetes research at Stanford University by providing key resources dedicated to supporting research, training and clinical activities focused on diabetes. Stanford has a well- known tradition and reputation for academic excellence, scientific innovation, and clinical care, united in a true University located on a single campus that facilitates and encourages interaction between scientists and clinicians from different disciplines. Stanford is the heart of Silicon Valley, an epicenter of innovation and calculated risk-taking, whose technology companies, start-ups, and mobile health companies partner with SDRC faculty in unique and growing collaborations to advance diabetes research and care. The SDRC is comprised of 94 investigators in 23 departments from the Schools of Medicine, Engineering, and Humanities & Sciences. The SDRC mission is to foster innovation, new knowledge, and training in basic and translational diabetes-related research, leading to improved diagnosis, treatment and prevention of diabetes and its complications. The SDRC consists of: 1) Administrative Component that coordinates the scientific, organizational, and outreach activities; 2) Biomedical Research Component that recruits and selects SDRC- affiliated investigators and supervises the research cores that facilitate and enhance their research; 3) Pilot and Feasibility Program that facilitates the development of new investigators into independent scientists and encourages scientists in other fields to enter the field of diabetes research; and 4) Enrichment, Training, and Outreach Program that fosters an environment conducive to collaborative, interdisciplinary research on diabetes. NIH support for the SDRC is greatly amplified by: 1) Stanford's sustained commitment to provide research space and additional financial resources; 2) a diverse, comprehensive array of research core services at Stanford, which allows NIH funds to support unique, diabetes-related research cores; and 3) collaborative efforts with other NIH-funded research centers at Stanford. The SDRC is evolving and dynamic, including additions to its investigator base and research areas, expanded focus on clinical and translational research, and evolution of core support to provide unique, indispensable core services devoted to diabetes research. Because of the strategic plan to create a strong Stanford Diabetes Research Center, and the culture of innovation this Center at Stanford creates, SCRC-affiliated investigators have made and are poised to continue making important scientific contributions related to diabetes, obesity, and metabolism.

中心概述摘要斯坦福糖尿病研究中心（SDRC）体现了长期战略计划的高潮斯坦福大学医学院，创建一个在精湛的，合作的基础上建立的主要课程研究基本，临床和翻译问题的研究人员着重于改善糖尿病护理。支持该P30应用程序将通过提供关键资源来利用斯坦福大学的糖尿病研究致力于支持糖尿病的研究，培训和临床活动。斯坦福有一个很好的已知的传统和声誉以学术卓越，科学创新和临床护理而闻名，大学位于一个校园中，促进并鼓励科学家与来自不同学科的临床医生。斯坦福大学是硅谷的中心，是创新的中心和计算出的冒险，其技术公司，初创企业和移动健康公司与 SDRC教职员工进行了独特而不断增长的合作，以推动糖尿病研究和护理。 SDRC是由来自医学，工程和人文学院的23个部门的94名调查人员组成科学。 SDRC的使命是促进基本和翻译的创新，新知识和培训与糖尿病相关的研究，导致糖尿病及其ITS的诊断，治疗和预防的改善并发症。 SDRC包括：1）协调科学的行政组件，组织和外展活动； 2）招募和选择SDRC-的生物医学研究成分附属的研究人员并监督促进和增强其研究的研究核心； 3）飞行员和可行性计划，促进新研究人员向独立科学家和鼓励其他领域的科学家进入糖尿病研究领域。 4）丰富，培训和推广计划促进了有利于协作，跨学科研究的环境糖尿病。 NIH对SDRC的支持大大扩大了：1）斯坦福的持续承诺提供研究空间和其他财务资源； 2）一系列多样化的研究核心服务在斯坦福大学，允许NIH资金支持与糖尿病相关的独特研究核心； 3）合作在斯坦福大学的其他NIH资助的研究中心努力。 SDRC正在发展和动态，包括在其研究者基础和研究领域的补充，扩大了关注临床和转化研究的关注，以及核心支持的演变，以提供专门针对糖尿病研究的独特，必不可少的核心服务。由于制定了强大的斯坦福糖尿病研究中心的战略计划，以及 Stanford Creates的创新中心，SCRC附属的调查人员已经做出了并准备继续做出与糖尿病，肥胖和代谢有关的重要科学贡献。